SCHEMBL18654317

SCHEMBL18654317

CCOC(=O)c1cnc2ccc(N3CCC(F)C3)nn12

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 3/20 0.44
▸ NPC1 O15118 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ RXFP1 Q9HBX9 3/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ KMT2A Q03164 1/20 0.41
▸ AAK1 Q2M2I8 4/20 0.40
▸ NTRK1 P04629 2/20 0.39
▸ DPP4 P27487 1/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ HRH3 Q9Y5N1 1/20 0.38
▸ DGAT1 O75907 1/20 0.37
▸ SOAT1 P35610 1/20 0.37
▸ NTRK3 Q16288 1/20 0.37
▸ NTRK2 Q16620 1/20 0.37
▸ TGFBR1 P36897 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14896633 1.00 IRAK4 (0.44) IRAK4NPC1RAB9ARXFP1KDM4E
SCHEMBL21637228 0.84 NPC1 (0.58) IRAK4NPC1RAB9ARXFP1KDM4E
SCHEMBL14881458 0.83 IRAK4 (0.47) IRAK4AAK1NTRK1DPP4PIM1
SCHEMBL14881490 0.83 IRAK4 (0.47) IRAK4AAK1NTRK1DPP4PIM1
SCHEMBL21765966 0.82 IRAK4 (0.46) IRAK4AAK1NTRK1PIM1NTRK3
SCHEMBL21765944 0.82 IRAK4 (0.48) IRAK4AAK1NTRK1PIM1TGFBR1
SCHEMBL18654880 0.82 IRAK4 (0.48) IRAK4AAK1NTRK1PIM1TGFBR1
SCHEMBL18654925 0.82 IRAK4 (0.48) IRAK4AAK1NTRK1PIM1TGFBR1
SCHEMBL14881882 0.78 IRAK4 (0.49) IRAK4NPC1RAB9AKMT2ANTRK1
SCHEMBL21765939 0.78 PDE10A (0.44) IRAK4KDM4EAAK1NTRK1PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3840832-B1 IMIDAZO[1,2-B]PYRIDAZINES AS TRK INHIBITORS BENEVOLENTAI BIO LTD (GB) 2023-10-11 — — EP disclosed
WO-2022234287-A1 IMIDAZOPYRIDAZINE DERIVATIVES USEFUL AS TRK INHIBITORS BENEVOLENTAI BIO LIMITED (GB) 2022-11-10 — — WO disclosed
WO-2021148807-A1 PHARMACEUTICAL COMPOSITIONS AND THEIR USES BENEVOLENTAI BIO LIMITED (GB) 2021-07-29 — — WO disclosed
WO-2021148805-A1 TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING IMIDAZO[1,2-B]PYRIDAZINE COMPOUNDS BENEVOLENTAI BIO LIMITED (GB) 2021-07-29 — — WO disclosed
WO-2021098745-A1 PREPARATION AND APPLICATION OF A CLASS OF PROTEIN RECEPTOR KINASE INHIBITORS 上海轶诺药业有限公司 2021-05-27 — — WO disclosed
WO-2020039209-A1 IMIDAZO[1,2-B]PYRIDAZINES AS TRK INHIBITORS BENEVOLENTAI BIO LIMITED (GB) 2020-02-27 — — WO disclosed
WO-2020016594-A1 IMIDAZO[1,2-B]PYRIDAZINE DERIVATIVES AS TRK INHIBITORS BENEVOLENTAI BIO LIMITED (GB) 2020-01-23 — — WO disclosed
EP-2768509-B1 SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC (US) 2017-03-22 — — EP disclosed
Send feedback